Metronidazole Injection, Solution
Product Images NDC 80830-2465

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metronidazole (NDC 80830-2465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Metronidazole Injection Usp 1)

FDA Label Image

1 (Metronidazole Injection Usp 2)

1 (Metronidazole Injection Usp 2)
This is a description of Metronidazole Injection, USP, a medication used for intravenous infusion. Each 100 mL container contains 500 mg of metronidazole, along with other ingredients. It is intended for single-dose use, and any unused portion should be discarded. The medication should not be mixed with other drugs. It should be stored in a moisture barrier overwrap at a temperature between 20°C and 25°C, with excursions permitted to 15°C to 30°C. It should also be protected from light. The product is manufactured in India and distributed by Amneal Pharmaceuticals.*
FDA Label Image

2 (Metronidazole Injection Usp 3)

2 (Metronidazole Injection Usp 3)
This text appears to be a description for a medication called Metronidazole Injection. The text includes instructions for opening the packaging, information about the sterility of the product, and the contents of each 100 mL of the injection. It also mentions the dosage, storage instructions, and manufacturing information. The text indicates that the medication should only be used for intravenous infusion and should not be mixed with any other medications. The manufacturing company is Puniska Healthcare Pvt. Ltd., a subsidiary of Amneal Pharmaceuticals Private Limited, located in Ahmedabad, India. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Unfortunately, there is no information available about the batch details.*
FDA Label Image

3 (Metronidazole Injection Usp 4)

3 (Metronidazole Injection Usp 4)
This is a description of a medication called Metronidazole Injection. It comes in a pack of 24 single-dose plastic containers, each containing 100 mL of sterile solution. The concentration of the medication is 500 mg per 100 mL (5 mg/mL). It is meant for intravenous infusion only, and any unused portion should be discarded. The solution also contains 790 mg of sodium chloride, 47.6 mg of dibasic sodium phosphate dried, and 22.9 mg of citric acid anhydrous. Each container has a sodium content of 14 mEq. The pH of the solution is 5.5, and the osmolarity is 308.66 mOsmol/L. The medication should be stored in a moisture barrier overwrap at a temperature of 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). It should be protected from light during storage. The medication is manufactured by Puniska Healthcare Pvt. Ltd., a subsidiary of Amneal Pharmaceuticals Private Limited, located in Ahmedabad, India. It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The product is labeled for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.